Clinically-validated and cost-effective solutions to healthcare professionals
In this recently published article, a multidisciplinary group from the Mayo Clinic (Rochester, Minnesota) details the discovery of a new type of thalassemia, a genetic
Thanks to modern sequencing protocols, diagnosing a genetic disease can be done in a cheap and easy way. Unfortunately, as we have seen with Cystic
Mon 20th March 2023 Oxford Nanopore’s devices with 4bases kits will enable decentralised, flexible scalability with a significant decrease in turnaround time for clinical researchers
Next Generation Sequencing (NGS) is an efficient way to keep track of disease-causing mutations in patients. Relying on this technique, a team of researchers from
February 28 is World Rare Disease Day. A day that, in addition to raising awareness on the topic, aims at stimulating change for the over
With an occurrence of about 1 out of 3,000 newborns in the Caucasian population, Mucoviscidosis, also known as Cystic Fibrosis (CF) is one of the
Powered by Com&Co© 2023
